ROCHE-NO16967



A Randomized, Open-label Study of the Effect of Intermittent Xeloda Versus iv Fluorouracil/Leucovorin, Both in Combination With Eloxatin, on Tumor Progression in Patients With Metastatic Colorectal Cancer Who Received Prior CPT-11 and 5-fluorouracil/Leucovorin
Capecitabine
NO16967
NCT00069108
malignant neoplasm of colon/rectum
Phase 3
 
January 2015